𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Notochord anomalies in the adriamycin rat model: A morphologic and molecular basis for the VACTERL association

✍ Scribed by J. Gillick; E. Mooney; S. Giles; J. Bannigan; P. Puri

Book ID
117827835
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
219 KB
Volume
38
Category
Article
ISSN
0022-3468

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Skeletal anomalies in the adriamycin-exp
Skeletal anomalies in the adriamycin-exposed prenatal rat: A model for VATER association
✍ Christine Kotsios; Jamal Merei; John M. Hutson; H. Kerr Graham πŸ“‚ Article πŸ“… 1998 πŸ› Elsevier Science 🌐 English βš– 823 KB

Vertebral and radial anomalies are prominent features of VATER (vertebral defects, anorectal anomaly, tracheoesophageal fistula with esophageal atresia, and radial dysplasia) association. It has been shown that exposure of the rat fetus to adriamycin produces a spectrum of anomalies, including esoph

Adriamycin-vitamin E combination therapy
Adriamycin-vitamin E combination therapy for treatment of prostate adenocarcinoma in the NB rat model
✍ John A. Nesbitt; Jeffery Smith; Gladstone McDowell; Joseph R. Drago πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 179 KB

Adriamycin used in combination with vitamin E (Tocopherol) was evaluated in the treatment of Nb rat prostate adenocarcinoma. Vitamin E has been shown to enhance the growth-inhibitory effects of adriamycin on human prostatic carcinoma cells in vitro. The adriamycin-vitamin E treatment groups had the

Molecular basis for the association betw
Molecular basis for the association between HLA DR4 and rheumatoid arthritis. From the shared epitope hypothesis to a peptidic model of rheumatoid arthritis
✍ Salvatore Albani; Jean Roudier πŸ“‚ Article πŸ“… 1992 πŸ› Elsevier Science 🌐 English βš– 354 KB

Susceptibility to rheumatoid arthritis (RA) maps to residues QKRAA/QRRAA in the third hypervariable region of the HLA DRI31 chain. Peptides from the same area of MHC class II molecules are able to modulate the T-cell repertoire by deleting self-reactive T-cells. The Epstein Barr virus glycoprotein g